Authors
Latest:
Rethinking Unmet Patient Medical Needs Through the Lens of the Patient JourneyBiopharma companies can foster patient-centered innovation by focusing on unmet needs along each stage of the patient journey while collaborating with key stakeholders directly or indirectly responsible for disease management.
Latest:
The State of Plastics Recycling in BioPharmaKey Challenges for Manufacturers and How MilliporeSigma is Leading Industry-Wide Change
Latest:
Just How ‘Real’ is Real-World Data?Addressing sources of tension on differentiating types of data.
Latest:
Biopharma Medical Affairs: Where We’ve Been and Where We’re HeadedA discussion with medical leaders on the present and future state of this vital biopharmaceutical function.
Latest:
Advancing COPD Research: Harnessing Wearable Sensors and Remote Monitoring for Improved InsightsWearable sensors and remote monitoring technology can help HCPs monitor and manage COPD more effectively.
Latest:
2024 Pipeline Report: First-World FocusPharm Exec’s 19th annual report on the trends of the day in drug development examines the surging investment in new treatments and advances for so-called “first-world” conditions, capturing the landscape of five expanding therapeutic areas: weight loss, osteoarthritis, Alzheimer’s disease, COPD, and psychedelics.
Latest:
Recent Federal Circuit Developments in Patent LicensingUnderstanding of recent legal developments can help companies avoid infringement.
Latest:
Pharma and AI: 2021 and BeyondFerdi Steinmann looks at pharma's current relationship with AI and how it is set to evolve.
Latest:
Bringing Biosimilars to Market in EuropeIf the life sciences sector can support healthcare professionals to gain confidence in substituting original treatments with new biosimilars, prices will reduce and patient outcomes will be enhanced.
Latest:
Viable Options: Packaging and Partnering for Successful Storage and Transport of Conventional Cold-Chain Vaccines for Covid-19***Live: Thursday, February 25, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET*** As strategic planning among manufacturers and logistics partners commences, this webinar will serve as a platform to discuss service offerings and explore the most effective possible solutions. *** On demand until Feb. 25, 2022***
Latest:
FDA Inspection and Enforcement Developments During the COVID-19 PandemicMitigating the risks of development, authorization, and marketing for new therapies following "new normal" created by COVID-related violations.
Latest:
Remembering That TIME Magazine Issue; Celebrating Progress in Patient EngagementLooking to the past reminds industry of great strides taken in clinical research for patients.
Latest:
The View From the ForefrontMatthew Howes, President at Greater Than One, discusses what to expect in the next twelve months in healthcare marketing.
Latest:
Empowering Prior Authorization ProfessionalsA look at the rise of prior authorization certified specialists (PACS)—and their value in improving patient access and outcomes.
Latest:
Don’t Waste A Crisis: How Paratek is Navigating the Business Implications of the COVID-19 PandemicA look at how pharmaceutical company, Paratek is navigating the launch of a new antibiotic during the COVID-19 pandemic.
Latest:
Beyond Medicines: Pharma's Journey with Patient Family Advisory CouncilsIncluding patient and family feedback in our discussions will help shape our understanding of their perception of provided care and services and how we operate as a whole.
Latest:
New Technologies Come with New Litigation RisksCybersecurity vulnerabilities embedded in AI and machine learning pose significant litigation risks as life sciences companies move to digital technologies.
Latest:
The Untapped Potential of Behavioral Science in Medical AffairsHistorically, Medical Affairs teams have relied on reporting only empirical evidence such as efficacy and tolerability profiles to influence uptake of a new drug or therapy. Here, Ben Routley and Mark Pringle explore the scope for applying behavioral science techniques to improve the impact of client communications.
Latest:
As Pharma Continues to Adapt to AI, the POSA Standard will Need to Equally AdaptU.S. patent law will have to adapt to the use of AI in the life sciences industry.
Latest:
Consolidating your Learning Tech EnvironmentIT Leaders in Life Sciences discuss the consolidation of the learning tech environment to help shift the training effectiveness conversation from anecdotal evidence to data-driven understanding.
Latest:
Comparing Three Common Pharma Communication AvenuesPavel Klymenko, Head of Omnichannel at Viseven, compares three top approaches to pharma communication and elucidates which are here to stay.
Latest:
How Biopharma Can Accelerate Innovation and Sustain GrowthThere are clear pathways that biopharma companies can take to sustain growth and remain competitive.
Latest:
How to Stand Out in the Wellness Space as a Pharma BrandKey steps in relationship-building beyond just treatment options.
Latest:
Defending Against Label-Based LawsuitsBest practices for defending against lawsuits based on pharmaceutical labeling, including avenues for early resolution of the case and, as necessary, strategies for developing the best evidence for defense.
Latest:
How COVID-19 Has Affected Launches of New Oncology Therapies in the U.S.Several months into the COVID-19 pandemic, this article takes a look back at how the launches of new oncology therapies have been impacted.
Latest:
There’s a New Way to Omnichannel: Orchestrating Experiences to Drive Sales, Savings and SatisfactionWebinar Date/Time: Wed, Nov 1, 2023 11:00 AM EDT
